| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/24/2009 | WO2009054863A3 Human antibodies that bind cd19 and uses thereof |
| 09/24/2009 | WO2009049013A3 Cholera vaccines |
| 09/24/2009 | WO2009044279A3 Peptides having antimicrobial and/or biosurfactant properties |
| 09/24/2009 | WO2004045516A9 Compositions and methods for the diagnosis and treatment of tumor |
| 09/24/2009 | WO2002079384A9 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/24/2009 | US20090241226 Gene Encoding Lignan Methylation Enzyme |
| 09/24/2009 | US20090241219 Gdc-2 genes conferring herbicide resistance |
| 09/24/2009 | US20090241207 Expression of heterologous genes according to a targeted expression profile |
| 09/24/2009 | US20090241202 Domain-grafted antibodies |
| 09/24/2009 | US20090240039 Polypeptide fusion |
| 09/24/2009 | US20090239809 Process For Preparing Peptide Products For Promoting Cholecystokinin Secretion And Use Of The Peptide Products |
| 09/24/2009 | US20090239801 Modified Fusion Polypeptides |
| 09/24/2009 | US20090239794 Hcv f protein and uses thereof |
| 09/24/2009 | US20090239790 Novel recombinant proteins with n-terminal free thiol |
| 09/24/2009 | US20090239788 Recombinant or transgenic factor vii compound having a majority of glycan, biantennary, bisialylated and non-fucosylated forms |
| 09/24/2009 | US20090239264 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates |
| 09/24/2009 | US20090239263 Expression Control Using Antibody Expression Optimisation Sequences |
| 09/24/2009 | US20090239262 Affinity Polypeptide for Purification of Recombinant Proteins |
| 09/24/2009 | US20090239261 ASSEMBLY OF WILD-TYPE AND CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES (VLPs) |
| 09/24/2009 | US20090239260 Fungal Transcriptional Activator Useful In Methods for Producing Polypeptides |
| 09/24/2009 | US20090239259 Mammalian expression vectors and uses thereof |
| 09/24/2009 | US20090239258 comprising the nucleotide sequence of SEQ ID NO:98 and/or the nucleotide sequence of SEQ ID NO:100; for diagnosing at least one IL-6 related condition in a cell, tissue, organ, animal or patient |
| 09/24/2009 | US20090239249 Novel thermostable gluconate dehydratase and use thereof |
| 09/24/2009 | US20090239239 Eukaryotic amadoriase having excellent thermal stability, gene and recombinant dna for the eukaryotic amadoriase, and process for production of eukaryotic amadoriase having excellent thermal stability |
| 09/24/2009 | US20090239216 Novel Tannase Gene And Protein Thereof |
| 09/24/2009 | US20090238922 Proteases |
| 09/24/2009 | US20090238843 Recombinant mva capable of expressing structural hcv antigens |
| 09/24/2009 | US20090238841 Hiv vaccine formulations |
| 09/24/2009 | US20090238836 Hip kinase for fertility control |
| 09/24/2009 | US20090238832 Novel compositions and method for the treatment of psoriasis |
| 09/24/2009 | US20090238823 Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| 09/24/2009 | US20090238822 Chimeric Hepatitis C Virus Antigens For Eliciting an Immune Response |
| 09/24/2009 | US20090238789 Modified erythropoietin polypeptides and uses thereof |
| 09/24/2009 | US20090238755 Use of antibodies or binding portions thereof, probes, ligands, or other biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 09/23/2009 | EP2103691A1 T helper cell epitopes |
| 09/23/2009 | EP2103629A1 Gamma -1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 09/23/2009 | EP2103628A1 Anti-claudin-3 monoclonal antibody, and treatment and diagnosis of cancer using the same |
| 09/23/2009 | EP2102355A2 Long acting proteins and peptides and methods of making and using the same |
| 09/23/2009 | EP2102354A2 Apparatus and methods for osmotically shocking cells |
| 09/23/2009 | EP2102240A2 Overexpression of the chaperone bip in a heterokaryon |
| 09/23/2009 | EP2102238A2 Cd44 antibodies |
| 09/23/2009 | EP2102230A2 Purifiction of romidepsin |
| 09/23/2009 | EP2101817A2 Human antibodies that bind cd19 and uses thereof |
| 09/23/2009 | EP1706428B1 Anti-cancer antibodies with reduced complement fixation |
| 09/23/2009 | EP1581797B1 Methods for the detection, analysis and isolation of nascent proteins |
| 09/23/2009 | EP1558758B1 Molecular identification of aspergillus species |
| 09/23/2009 | EP1501935B1 Low-cost production of peptides |
| 09/23/2009 | EP1478662B1 Method for producing hypoallergenic major birch pollen allergens rbet v 1 |
| 09/23/2009 | EP1360278B1 Lipase variants |
| 09/23/2009 | EP1234880B9 Novel protein tab2 |
| 09/23/2009 | EP1086138B1 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 09/23/2009 | EP1073734B1 Tumor associated nucleic acids and uses therefor |
| 09/23/2009 | EP1003781B1 Interleukin-18 binding proteins, their preparation and use |
| 09/23/2009 | CN101541972A A method of producing recombinant biological products |
| 09/23/2009 | CN101538602A Extraction method of fish skin collagen |
| 09/23/2009 | CN101538601A Method for producing bovine-bone peptone by enzyme technology |
| 09/23/2009 | CN101538600A Method for yeast biosynthesis of glutathione |
| 09/23/2009 | CN101538583A Preparation method of natural antimicrobial beta-alexin 9 recombinant protein of duck |
| 09/23/2009 | CN101538582A Preparation method of natural antimicrobial beta-alexin 2 recombinant protein of duck |
| 09/23/2009 | CN101538578A Recombinant bovine tuberculosis specific antigen protein with three fused genes and preparation method thereof |
| 09/23/2009 | CN101538572A Recombinant lactic acid bacteria containing recombinant alpha-2b interferon and application thereof |
| 09/23/2009 | CN101538539A Culture medium for biosynthesis of virginiamycin M |
| 09/23/2009 | CN101538331A Single chain antibody-lidamycin fusion protein ER (Fv-LDP) targeting EGFR |
| 09/23/2009 | CN101538328A Humanized neutralizing engineered antibody for targeting avian influenza virus H5N1 |
| 09/23/2009 | CN101538320A Artificial zinc finger protein transcription factor capable of specifically regulating up HO-1 gene expression and application thereof |
| 09/23/2009 | CN101538318A Signal peptide, coding genes thereof and application |
| 09/23/2009 | CN101538307A Dehydroepiandrosterone hapten, artificial antigen and antibody as well as preparation method and application thereof |
| 09/23/2009 | CN101538266A Rogridone hapten, artificial antigen and antibody as well as preparation method and application thereof |
| 09/23/2009 | CN101537180A Recombinant production of mixtures of antibodies |
| 09/23/2009 | CN100543144C Method for preparing functional protein peptide |
| 09/23/2009 | CN100543141C Method for producing gene engineering recombination 192 peptide human growth hormone |
| 09/22/2009 | US7592439 Apolipoprotein receptor specific monoclonal antibody for use in the prevention and treatment of cell proliferative disorders |
| 09/22/2009 | US7592438 Human gene |
| 09/22/2009 | US7592437 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/22/2009 | US7592434 Pectate lyases, nucleic encoding them and methods for making and using them |
| 09/22/2009 | US7592433 cyclic peptides, signal peptide having animal or plant diagnostic/therapeutic properties; cyclization an encoded amino acid sequence within a cell or cell membrane; protecting crop plants, insecticidal proteins from pest |
| 09/22/2009 | US7592432 selectively splitting the polypeptide at a Cys-His site, by hydrolysis in presence of a palladium promotor dissolved in formic acid; purification with by-product inhibition |
| 09/22/2009 | US7592427 Antibodies to IL-21 receptor |
| 09/22/2009 | US7592426 conjugated drug for drug targeting at pancreatic cancer cell; biodrugs as antitumor agent, anticarcinogenic agent; free of side effect |
| 09/22/2009 | US7592425 antibody binds a polypeptide; use in tissue targeted therapy; Interleukins; immunoglobulins; for stimulating proliferation and/or development of hematopoietic cells in vitro and in vivo; polypeptide-toxins |
| 09/22/2009 | US7592310 Induction of antibiotic proteins and peptides by LAIT/sCD14-protein |
| 09/22/2009 | US7592159 Antibiotic alternatives |
| 09/22/2009 | US7592158 Polypeptides and polynucleotides, including vaccines against bacterial infections such as otitis media in infants and children, and pneumonia in elderlies |
| 09/22/2009 | US7592156 Synthetic dog/human chimeric C-C chemokine receptor 2B |
| 09/22/2009 | US7592013 Administering a recombant food-grade bacterium expressing a trefoil peptide;delivering a TFF1 trefoil peptide in vivo expressed by a Lactococcus for lesion damage to the mucous membranes of the mouth caused by radiation; antinflammatory agents; gastrointestinal disorders |
| 09/22/2009 | US7592011 Streptococcal peptide for use in prevention and treatment of microorganismal infection; bactericides; microbiocides |
| 09/22/2009 | US7592010 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 09/22/2009 | US7592007 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
| 09/22/2009 | US7592005 Multiple myeloma; targeting antibody conjugated with a radionuclide or other cytotoxic substance |
| 09/22/2009 | US7592004 Lyophilizing an aqueous formulation comprising a high concentration, 50 mg/ml or more of an immunoglobulin IgG antibody, in particular, daclizumab, in 5-25 mM histidine buffer, having pH 5.5-6.5, 0.005%-0.03% polysorbate, and sucrose |
| 09/22/2009 | CA2346927C Method for generating diversity |
| 09/22/2009 | CA2295957C Canine interleukin 18, canine interleukin 1.beta. converting enzyme, dna sequences encoding these, interleukin 18 production method and canine immune disease remedy |
| 09/22/2009 | CA2241111C Process for the microbial production of amino acids by boosted activity of export carriers |
| 09/22/2009 | CA2239167C Aldolase catalytic antibody |
| 09/22/2009 | CA2200980C Mammalian receptors for modified low-density lipoprotein |
| 09/17/2009 | WO2009114693A1 Method for identifying cells suitable for large-scale production of recombinant proteins |
| 09/17/2009 | WO2009114380A1 Expression of catalase in trichoderma |
| 09/17/2009 | WO2009113742A1 Method of producing genetically engineered antibody |
| 09/17/2009 | WO2009113665A1 Method of producing drug for swine atrophic rhinitis |
| 09/17/2009 | WO2009113661A1 Cyclic compound and salt thereof |